FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves New Warnings on Covid mRNA Vaccines

[ Price : $8.95]

FDA requires and approves updates to the prescribing information for Pfizers Comirnaty Covid-19 mRNA vaccine and Modernas Spikevax...

Stop FDAs Sudden Biosecurity Overreach: Newsletter

[ Price : $8.95]

A Global Biodefense online post says FDAs sudden decision to halt clinical trials that send samples overseas for processing can hu...

Makarys FDA Voucher Program Questioned

[ Price : $8.95]

UPenn medical school professor Holly Lynch says there are many questions about the new FDA Commissioners National Priority Voucher...

House Committee Advances FDA Budget Bill

[ Price : $8.95]

The U.S. House Appropriations Committee advances in a 35 to 27 vote FDAs fiscal year 2026 spending bill.

Safety Alert on Medtronic Esophagus pH Monitor

[ Price : $8.95]

FDA posts a safety alert on Medtronic subsidiary Given Imaging and certain Bravo CF Capsule delivery devices, which are designed t...

Safety Communication on 2 Elevidys-related Deaths

[ Price : $8.95]

FDA issues a safety communication about two reports of fatal acute liver failure following treatment of Duchenne Muscular Dystroph...

CGMP Issues in Pushclean Records Review

[ Price : $8.95]

FDA warns Turkeys Pushclean Technology about CGMP violations in its manufacturing of over-the-counter drug products.

QS, MDR Violations at S. Koreas Aju Pharm

[ Price : $8.95]

FDA warns South Koreas Aju Pharm about QS and MDR violations in its production of two Class 2 medical devices.

FDA Skips Panel Review for Capricor Cell Therapy

[ Price : $8.95]

FDA says there will be no advisory committee review of Capricor Therapeutics BLA for Deramiocel, the companys lead cell therapy ca...

Nektar Sees Promising Data with Dermatitis Drug

[ Price : $8.95]

Nektar Therapeutics reports promising results from a mid-stage clinical trial of its experimental therapy rezpegaldesleukin for pa...